CVC. Robert Valeri

C. Robert Valeri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


C. Robert Valeri has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Gina Ragno

    From the Naval Blood Research Laboratory, Boston University School of Medicine; Brigham & Women's Hospital; and the Massachusetts General Hospital, Boston, Massachusetts; and the Massachusetts Institute of Technology, Cambridge, Massachusetts

    13 shared publications
  • Linda E. Pivacek

    From the Naval Blood Research Laboratory and Surgical Service, Boston University School of Medicine; the Brigham and Women's Hospital; and Harvard Medical School, Boston, Massachusetts; and the Surgical Service, Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts

    6 shared publications
  • G. Ragno

    Naval Blood Research Laboratory, Boston University School of Medicine, Boston, MA, USA

    4 shared publications
  • Rithy Srey

    From the Naval Blood Research Laboratory, Boston University School of Medicine, Boston, Massachusetts

    4 shared publications
  • George P. Cassidy

    From the Naval Blood Research Laboratory, Boston University School of Medicine, Boston, Massachusetts

    3 shared publications
  • Albert Giorgio

    From the Naval Blood Research Laboratory, Boston University School of Medicine, Boston, Massachusetts

    2 shared publications

Latest Publications

  • Effect of thrombopoietin alone and a combination of cytochalasin B and ethylene glycol bis(β-aminoethyl ether) N,N′-tetraacetic acid-AM on the survival and function of autologous baboon platelets stored at 4°C for as long as 5 days

    by C. Robert Valeri, Gina Ragno, Peter W. Marks, David J. Kuter, Robert D. Rosenberg, Thomas P. Stossel

    PLTs stored at 22 degrees C have the potential for bacterial contamination, a problem that could be reduced by 4 degrees C storage. Nevertheless, PLTs stored at 4 degrees C exhibit a significantly reduced life span. This study was performed to determine whether treatment of PLTs with thrombopoietin or cytochalasin B plus ethylene glycol bis(beta-aminoethyl ether) N,N'-tetraacetic acid (EGTA)-AM could prevent exponential loss of PLTs stored at 4 degrees C. Autologous baboon PLTs were stored at 22 or 4 degrees C. The 4 degrees C stored PLTs were treated with 1.5 ng per mL thrombopoietin, with 1 micro mol per L cytochalasin B, and 80 micromol per L EGTA-AM (cyto-EGTA) or not treated and labeled with (111)In-oxine to study their in vivo recovery and life span. PLT function was assessed by correction of an aspirin-induced prolonged bleeding time. Aggregation responses and morphology were also assessed. PLTs stored at 22 degrees C had normal in vivo recovery and linear survival. PLTs stored at 4 degrees C, whether or not they were treated with thrombopoietin, had normal recovery and exponential survival. Aggregation of cyto-EGTA-treated PLTs was similar for PLTs stored at 4 degrees C and fresh PLTs, but decreased in PLTs stored at 22 degrees C for 5 days. The addition of cyto-EGTA to PLTs before 4 degrees C storage inhibited morphologic changes that occurred in PLTs stored at 22 degrees C and cold-induced PLT clumping, but did not prevent exponential disappearance of the PLTs. Addition of thrombopoietin or cyto-chalasin B and EGTA-AM to PLTs before 4 degrees C storage did not prevent exponential loss of PLTs.


  • Comparison of radioisotope methods and a nonradioisotope method to measure the RBC volume and RBC survival in the baboon

    by C. Robert Valeri, Hollace MacGregor, Albert Giorgio, Rithy Srey, Gina Ragno

    BACKGROUND:  RBC volume, 24‐hour posttransfusion survival, and life span can be measured with radio‐isotopes and nonradioactive procedures.STUDY DESIGN AND METHODS:  RBC volume was measured directly with autologous baboon RBCs labeled with biotin‐X‐N‐hydroxysuccinimide (NHS), 51Cr, 99mTc, and 111In‐oxine and indirectly from the 125I plasma volume and the total body Hct. Twenty‐four‐hour posttransfusion survival and life span were measured in autologous fresh baboon RBCs labeled with 51Cr, 111In‐oxine, 99mTc, and biotin‐X‐NHS.RESULTS:  Significantly larger RBC volumes were observed when the fresh autologous RBCs were labeled with 51Cr, 111In‐oxine, or 99mTc than when they were labeled with the nonradioactive biotin‐X‐NHS. Twenty‐four‐hour posttransfusion survival values were signifi‐cantly lower in the RBCs labeled with 111In‐oxine or 99mTc than in the RBCs labeled with 51Cr.CONCLUSIONS:  The greater in vivo elution of 51Cr, 111In‐oxine, and 99mTc than that of biotin‐X‐NHS influenced the measurements of RBC volume, 24‐hour posttransfusion survival, and life span of the fresh baboon RBCs.


  • Effect of WBC reduction and storage temperature on PLTs frozen with 6 percent DMSO for as long as 3 years

    by C. Robert Valeri, Rithy Srey, Joseph P. Lane, Gina Ragno

    BACKGROUND: PLTs frozen with 6 percent DMSO can be stored at −80°C for 2 years, while those frozen with 5 percent DMSO at −150°C can be stored for at least 3 years. The more rapid deterioration seen in PLTs frozen at −80°C may be due to the presence of granulocytes. The effects of storage temperature and WBC reduction on PLTs frozen with DMSO and the breakage of the PVC plastic bags stored at −80 and −135°C were assessed.STUDY DESIGN AND METHODS: Apheresed PLT‐rich plasma (PRP) was either divided into two equal volumes where one volume was WBC‐reduced and the other volume was not or filtered or not and then divided into two equal volumes. PLTs frozen with 6 percent DMSO were stored in PVC plastic bags at either −80 or −135°C for as long as 3 years.RESULTS: After 2 years of storage at −80°C, the PLTs exhibited satisfactory freeze‐thaw‐wash values regardless of whether or not they were WBC‐reduced, but after 2 to 3 years of storage at −80°C, the PLTs had significantly reduced freeze‐thaw‐wash values. Freeze‐thaw‐wash values were not reduced in PLTs stored at −135°C for up to 3 years.CONCLUSIONS: WBC reduction did not improve freeze‐thaw‐wash recovery values in PLTs stored at −80 or −135°C for up to 3 years, but reducing the storage temperature from −80 to −135°C did. Breakage of PVC plastic bags stored at −135°C was excessive.


  • Circulation and distribution of autotransfused fresh, liquid‐preserved and cryopreserved baboon platelets

    by C. R. Valeri, A. Giorgio, H. Macgregor, G. Ragno

    Background and Objectives Studies were carried out in five healthy male baboons to determine the 111indium oxine (111In‐oxine) survival of autologous fresh, liquid‐preserved and cryopreserved platelets. Simultaneous organ‐distribution studies were performed to determine the percentage uptake of platelets by the spleen and/or liver.Materials and Methods Each of five baboons was transfused, on three different occasions, with autologous fresh platelets stored at 22 °C for 18 h, liquid‐preserved platelets stored at 22 °C for 5 days and washed previously frozen platelets, labelled with 111In‐oxine.Results In vivo recovery at 2 h was 81% for the fresh platelets, 54% for the previously frozen platelets and 44% for the 5‐day‐old liquid‐preserved platelets. The weighted mean life span was 5·4 days for fresh platelets, 4·2 days for previously frozen platelets and 2 days for liquid preserved platelets. Increased radioactivity was detected over the liver 2 h after transfusion for both the previously frozen and liquid‐preserved platelets.Conclusions Cryopreserved platelets and liquid‐preserved platelets stored at 22 °C for 5 days had reduced survival 2 h post‐transfusion and reduced life span values compared to fresh platelets. In addition, the finding of increased radioactivity over the liver in the baboons that received cryopreserved and liquid‐preserved platelets suggested that the liver was the site for removal of the non‐viable platelets.


  • Circulation and hemostatic function of autologous fresh, liquid‐preserved, and cryopreserved baboon platelets transfused to correct an aspirin‐induced thrombocytopathy

    by C. Robert Valeri, Hollace MacGregor, Albert Giorgio, Gina Ragno

    BACKGROUND : The survival of fresh and preserved platelets has been used primarily to determine their therapeutic effectiveness. The function of the fresh and preserved platelets has been difficult to assess. In stable thrombocytopenic patients, platelet function of fresh and preserved allogeneic platelets is evaluated by the reduction in bleeding time. In this study of healthy male baboons, both the survival and function of autologous fresh, liquid‐preserved, and cryopreserved platelets in the correction of an aspirin‐induced thrombocytopathy was evaluated. STUDY DESIGN AND METHODS : Five healthy male baboons were studied on eight occasions over a 4‐year period. To produce a prolonged bleeding time, the baboon was administered 325 mg of aspirin 18 hours before receiving autologous transfusion. The fresh, liquid‐preserved, and previously frozen washed platelets were labeled with 111 In‐oxine before autologous transfusion. The autologous, nonaspirinated platelets' ability to reduce the aspirin‐induced prolonged bleeding time and increase the shed blood thromboxane B 2 level at the template bleeding time site was studied. RESULTS : Platelets stored at 22°C for 48 hours had in vivo recovery values similar to those platelets stored for 18 hours, and they significantly reduced the bleeding time and increased the shed blood thromboxane level after transfusion. Platelets stored at 22°C for 72 hours had in vivo recovery values similar to those platelets stored for 18 hours, but the bleeding time was not corrected after transfusion, although there was a significant increase in the shed blood thromboxane B 2 level. The cryopreserved platelets significantly reduced the bleeding time and significantly increased the shed blood thromboxane level after transfusion. Cryopreserved platelets had better in vivo survival and function than the 5‐day liquid‐stored platelets. CONCLUSIONS : The survival of autologous fresh, liquid‐preserved, or cryopreserved platelets did not correlate with their function to reduce an increased bleeding time in baboons treated with aspirin.


  • Survival and function of baboon RBCs released from clotted blood and washed before autologous transfusion

    by C. Robert Valeri, Gina Ragno, Linda E. Pivacek, Richard C. Dennis, Herbert B. Hechtman, Shukri F. Khuri

    BACKGROUND: One alternative to an allogeneic transfusion is the salvaging of the patient's own shed blood. In this study, baboon blood was allowed to clot and the RBCs that were released from the clotted blood lysed with and without urokinase were washed before autologous transfusion. STUDY DESIGN AND METHODS: Forty‐four studies were done in 13 baboons (Papio cynocephalus or Papio anubis) over a 3‐year period. In 24 studies, a 50‐mL volume of blood was collected without an anticoagulant and stored at 22°C for as long as 72 hours before washing and autologous transfusion. In 20 other studies, a 50‐mL volume of blood was collected without an anticoagulant and allowed to clot for 30 to 60 minutes. Urokinase, ranging from 2,500 to 10,000 units per mL, was added, and the blood was stored at 22°C for 24 hours before washing and autologous transfusion. RESULTS: RBCs that were stored at 22°C without urokinase for 24 hours exhibited an in vitro recovery value of 45 percent, a 51Cr 24‐hour posttransfusion survival of 86 percent, and an index of therapeutic effectiveness of 39 percent. The 51Cr T50 value was normal at 14 days, and RBC oxygen‐transport function was slightly reduced. RBCs that were stored at 22°C for 24 hours with 10,000 units per mL of urokinase exhibited an in vitro recovery value of 89 percent, a 51Cr 24‐hour posttransfusion survival value of 86 percent, and an index of therapeutic effectiveness of 76 percent. The 51Cr T50 value was normal at 14 days, and the RBC oxygen‐transport function was only slightly reduced. CONCLUSION: Autologous baboon RBCs isolated from clotted blood treated or not treated with urokinase and washed before transfusion have excellent survival and normal or only slightly reduced oxygen‐transport function.


  • Survival, function, and hemolysis of shed red blood cells processed as nonwashed blood and washed red blood cells

    by C.RObert Valeri, Richard C Dennis, Gina Ragno, Linda E Pivacek, Herbert B Hechtman, Shukri F Khuri


  • Autologous platelet‐rich plasma isolated using the Haemonetics Cell Saver 5 and Haemonetics MCS+ for the preparation of platelet gel

    by E. M. O'NEill, W. M. Zalewski, L. J. Eaton, M. A. Popovsky, L. E. Pivacek, G. Ragno, C. R. Valeri

    Background and Objectives: We compared three methods of isolating platelet‐rich plasma (PRP) using the Haemonetics Cell Saver 5 and one method of isolating PRP by plateletpheresis using the Haemonetics MCS+. PRP contains both platelets and fibrinogen, which are used in the preparation of haemostatic agents.Materials and Methods: When the Haemonetics Cell Saver 5 was used, 500 ml of blood from each of 30 normal volunteer donors was collected into 70 ml of citrate–phosphate–dextrose (CPD) anticoagulant. In a further 14 normal volunteers, the Haemonetics MCS+ was used to isolate PRP by plateletpheresis using an acid citrate dextrose (ACD) to blood ratio of 1 : 9. In a separate study, CPD‐anticoagulated whole blood from another 30 volunteers was used for measurement of fibrinogen levels in the plasma and cryoprecipitate.Results: A larger volume of PRP can be collected using the Haemonetics Cell Saver 5 than by using the Haemonetics MCS+. The platelet concentration and the total number of platelets were higher in the PRP isolated using the Haemonetics MCS+ than in the PRP isolated by the three methods used with the Haemonetics Cell Saver 5, with differences in platelet concentration and PRP volume among the four methods. The mean fibrinogen level in the plasma was 253 mg % ± 47 (SD) and in the cryoprecipitate was 1085 mg % ± 304 (SD).Conclusions: The most appropriate method of PRP isolation for preparation of platelet gel is dependent upon the specific surgical procedure to be undertaken and the patient’s needs.